Scalable Genomics

Scalable Genomics provides bioinformatics software for plug-in-play analysis of Big Data from genomic sequencing of clinical, environmental, genomic, and forensic samples. Scalable Genomics Team: Ntrino Krampis

Read More

PHD Biosciences

We are developing an enzyme inhibitor with pico-­‐molar binding affinity and minimal toxicity as a once daily, oral therapeutic for the treatment of triple-­‐negative breast cancer. Nanomedics LLC Team: Michael Isaacman Andrew Mahon

Read More

GeneticaLens

GenicaLens introduces Well Child Lens: video-enhanced mobile applications for doctors and parents to clarify and streamline ALL aspects of autism screening and surveillance in toddlers – expanding to include other behavioral disorders birth to five. GeneticaLens Team: Louise Tiranoff

Read More

Optologix

Optologix — Our product uses light to activate gene expression in cells and animals, allowing for nontoxic, rapid, precisely timed and localized induction unmatched by chemical-based methods. Optologix Team: Kevin Gardner Laura Motta-Mena    

Read More

Sveikatal

Sveikatal, is focused on the management of oral cancer using a novel retinoid therapy, which acts through pathways controlled by Vitamin A and complements current therapies. Sveikatal Team: John Wagner, PhD Amy Chen, CFO

Read More

NY Protein Biologics

NY Protein Biologics will harness unique know-how and patent-pending processes to deliver products and develop new technologies that are central to the biotechnology and pharmaceutical industries. NY Protein Biologics Team: Greg Kornhaber Gregory Boel, PhD John Hunt, PhD  

Read More

PainQX

The PainQx System is algorithmic software that provides an accurate and objective way to measure chronic and acute pain in humans and animals. PainQX Team: Frank Minella  

Read More

S.A.L.T

S.A.L.T is a point of care medical device that rapidly & reliably measures salt levels in urine using 2 urine strips and a mobile app. S.A.L.T Team: Fantasia Powell, Founder Eliot Kim, Advisor  

Read More

NomoCan Pharmaceuticals

Utilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer. NomoCan Pharmaceuticals Team: Ehsan Sarafraz-Yazdi, PhD Kamyar Neshvadian, FRM  

Read More